0001415889-23-005819.txt : 20230403
0001415889-23-005819.hdr.sgml : 20230403
20230403174626
ACCESSION NUMBER: 0001415889-23-005819
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230330
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Bobae
CENTRAL INDEX KEY: 0001959158
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 23794127
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
3
1
form3-04032023_090415.xml
X0206
3
2023-03-30
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001959158
Kim Bobae
44 PROSPECT ST.
APT. 536
MORRISTOWN
NJ
07960
false
true
false
false
VP Reg. Affairs & Quality
Common Stock
9890
D
Restricted Stock Units
0
Common Stock
11000
D
Stock Options (right to buy)
21
2026-09-30
Common Stock
133
D
Stock Options (right to buy)
7.35
2026-12-07
Common Stock
266
D
Stock Options (right to buy)
33
2028-03-22
Common Stock
1200
D
Stock Options (right to buy)
13.20
2029-01-02
Common Stock
1000
D
Stock Options (right to buy)
7.50
2029-09-26
Common Stock
1166
D
Stock Options (right to buy)
1.52
2033-02-10
Common Stock
50000
D
Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
Not Applicable.
Fully vested and exercisable.
This option was granted on September 26, 2019. This option vests in quarterly installments over a four-years period from the date of grant.
This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.
/s/ Bobae Kim
2023-04-03